Genistein inhibits radiation-induced invasion and migration of glioblastoma cells by blocking the DNA-PKcs/Akt2/Rac1 signaling pathway.

Abstract

BACKGROUND AND PURPOSE:

Radiotherapy is the most important therapeutic measure against glioblastoma multiforme (GBM), which is regarded as the most common and highly lethal type of brain cancer. Nevertheless, most relapses originate in the close vicinity of the irradiated target volume. Genistein is a natural product that can suppress the invasive potential of cancer cells. In this study, DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-proficient and -deficient GBM cells were selected for in vitro and in vivo studies to investigate the inhibiting effects of genistein on radiation-induced invasion and migration and the corresponding mechanism.

MATERIALS AND METHODS:

GBM cell lines with or without genistein pre-treatment were irradiated with X-rays. Cell survival was determined using colony formation assay and the rate of cellular proliferation was analyzed with a real-time cell electronic sensing system. For in vitro study, invasion and migration abilities were evaluated via wound-healing and transwell assays, while protein expression was determined with western blotting. Genistein interaction with DNA-PKcs was estimated with pull-down, recombinant and binding assays. For in vivo study, cells were stereotactically injected into NOD-SCID mice to establish tumors. Hematoxylin and eosin and immunohistochemistry were used to assess the invasive potential of GBM.

RESULTS:

X-ray irradiation enhanced the migration and invasion of DNA-PKcs-positive but not DNA-PKcs-negative GBM cells. It also activated the DNA-PKcs/Akt2/Rac1 signaling pathway, which contributed to GBM malignant progression by aggravating GBM cell invasive potential. The study successfully demonstrated that genistein can specifically bind to DNA-PKcs and block the DNA-PKcs/Akt2/Rac1 pathway, thereby effectively inhibiting radiation-induced invasion and migration of GBM cells in vitro and in vivo. The present study emphasized that radiation-induced invasive potential is initiated by DNA-PKcs, which is a well-known double strand breaks (DSB) repair protein, and determined the exact site for genistein binding to DNA-PKcs.

CONCLUSION:

DNA-PKcs is not only a potential target for cancer therapy, but also a reliable biomarker for predicting radiation-induced invasion and migration of GBM cells. Thus, genistein might serve as a novel therapeutic strategy for treating GBM.

• Authors: Xiongxiong Liu, Qiqi Wang, Bingtao Liu, Xiaogang Zheng, Ping Li, Ting Zhao, Xiaodong Jin, Fei Ye, Pengcheng Zhang, Weiqiang Chen, Qiang Li
• Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (Radiother Oncol) Vol. 155 Pg. 93-104 (02 2021) ISSN: 1879-0887 [Electronic] Ireland
• PMID: 33129924 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020 Elsevier B.V. All rights reserved.

Chemical References

• DNA
• Genistein
• Akt2 protein, mouse
• DNA-Activated Protein Kinase
• Proto-Oncogene Proteins c-akt

Topics

• Animals
• Brain Neoplasms (radiotherapy)
• Cell Line, Tumor
• DNA
• DNA-Activated Protein Kinase (metabolism)
• Genistein (pharmacology)
• Glioblastoma (radiotherapy)
• Mice
• Mice, Inbred NOD
• Mice, SCID
• Neoplasm Recurrence, Local
• Proto-Oncogene Proteins c-akt
• Signal Transduction